Loading...
Zimmer Biomet Holdings, Inc.
ZBH•NYSE
Healthcare
Medical - Devices
$95.66
$-1.89(-1.94%)
Zimmer Biomet Holdings, Inc. (ZBH) Financial Performance & Income Statement Overview
Review Zimmer Biomet Holdings, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
3.85%
↑ 3.85%
Operating Income Growth
0.63%
↑ 0.63%
Net Income Growth
-11.74%
↓ 11.74%
Operating Cash Flow Growth
-5.20%
↓ 5.20%
Operating Margin
17.04%
↑ 17.04%
Gross Margin
71.05%
↑ 71.05%
Net Profit Margin
11.86%
↑ 11.86%
ROE
7.31%
↑ 7.31%
ROIC
6.60%
↑ 6.60%
Zimmer Biomet Holdings, Inc. (ZBH) Income Statement & Financial Overview
Review Zimmer Biomet Holdings, Inc.'s (ZBH) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $2.02B | $1.82B | $1.94B | $1.89B |
| Cost of Revenue | $586.70M | $538.60M | $763.40M | $719.80M |
| Gross Profit | $1.44B | $1.29B | $1.18B | $1.17B |
| Gross Profit Ratio | $0.71 | $0.70 | $0.61 | $0.62 |
| R&D Expenses | $108.50M | $111.60M | $109.40M | $107.90M |
| SG&A Expenses | $746.90M | $709.70M | $733.70M | $735.20M |
| Operating Expenses | $1.05B | $1.006B | $843.10M | $843.10M |
| Total Costs & Expenses | $1.63B | $1.46B | $1.61B | $1.56B |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $61.90M | $54.30M | $51.10M | $50.70M |
| Depreciation & Amortization | $263.60M | $250.90M | $243.20M | $238.60M |
| EBITDA | $614.50M | $532.50M | $645.30M | $631.10M |
| EBITDA Ratio | $0.30 | $0.29 | $0.30 | $0.30 |
| Operating Income | $389.00M | $279.50M | $335.50M | $326.30M |
| Operating Income Ratio | $0.19 | $0.15 | $0.17 | $0.17 |
| Other Income/Expenses (Net) | -$100.00M | -$49.20M | -$49.10M | -$50.80M |
| Income Before Tax | $289.00M | $230.30M | $302.20M | $215.10M |
| Income Before Tax Ratio | $0.14 | $0.13 | $0.16 | $0.11 |
| Income Tax Expense | $48.90M | -$18.90M | $59.10M | $42.30M |
| Net Income | $239.50M | $249.20M | $242.80M | $172.40M |
| Net Income Ratio | $0.12 | $0.14 | $0.13 | $0.09 |
| EPS | $0.00 | $1.23 | $1.18 | $0.84 |
| Diluted EPS | $0.00 | $1.23 | $1.18 | $0.84 |
| Weighted Avg Shares Outstanding | $202.30M | $202.30M | $205.70M | $205.20M |
| Weighted Avg Shares Outstanding (Diluted) | $203.00M | $203.00M | $206.40M | $206.20M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan